Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated withchemo-radiotherapy

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 37

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Oct 7, 2006; 12(37): 6032-6036
Published online Oct 7, 2006. doi: 10.3748/wjg.v12.i37.6032

Table 2 Toxicity evaluated

Citation: R RZ, Arias F, Bandres E, Cubedo E, Malumbres R, García-Foncillas J. Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated withchemo-radiotherapy. World J Gastroenterol 2006; 12(37): 6032-6036
URL: https://www.wjgnet.com/1007-9327/full/v12/i37/6032.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i37.6032

R RZ, Arias F, Bandres E, Cubedo E, Malumbres R, García-Foncillas J. Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated withchemo-radiotherapy. World J Gastroenterol 2006; 12(37): 6032-6036 [PMID: 17009404 DOI: 10.3748/wjg.v12.i37.6032]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.